These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37840517)

  • 1. A pocket companion to cell-free DNA (cfDNA) preanalytics.
    Bronkhorst AJ; Holdenrieder S
    Tumour Biol; 2024; 46(s1):S297-S308. PubMed ID: 37840517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms.
    Grabuschnig S; Bronkhorst AJ; Holdenrieder S; Rosales Rodriguez I; Schliep KP; Schwendenwein D; Ungerer V; Sensen CW
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of modern circulating cell-free DNA diagnostic tools for detection of specific tumour cells in clinical practice.
    Gašperšič J; Videtič Paska A
    Biochem Med (Zagreb); 2020 Oct; 30(3):030504. PubMed ID: 32774122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridging biological cfDNA features and machine learning approaches.
    Moser T; Kühberger S; Lazzeri I; Vlachos G; Heitzer E
    Trends Genet; 2023 Apr; 39(4):285-307. PubMed ID: 36792446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood has never been thicker: Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomas.
    Meriranta L; Pitkänen E; Leppä S
    Semin Hematol; 2023 Jul; 60(3):132-141. PubMed ID: 37455222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
    Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A
    Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953
    [No Abstract]   [Full Text] [Related]  

  • 7. New Perspectives on the Importance of Cell-Free DNA Biology.
    Bronkhorst AJ; Ungerer V; Oberhofer A; Gabriel S; Polatoglou E; Randeu H; Uhlig C; Pfister H; Mayer Z; Holdenrieder S
    Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
    Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S
    Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsy and its role in an advanced clinical trial for lung cancer.
    Johann DJ; Steliga M; Shin IJ; Yoon D; Arnaoutakis K; Hutchins L; Liu M; Liem J; Walker K; Pereira A; Yang M; Jeffus SK; Peterson E; Xu J
    Exp Biol Med (Maywood); 2018 Feb; 243(3):262-271. PubMed ID: 29405770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When Tissue Is the Issue: Expanding Cell-Free DNA "Liquid Biopsies" to Supernatants and Nonplasma Biofluids.
    Paulson V; Konnick EQ; Lockwood CH
    Clin Lab Med; 2022 Sep; 42(3):485-496. PubMed ID: 36150825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technical Advances in Circulating Cell-Free DNA Detection and Analysis for Personalized Medicine in Patients' Care.
    Sorbini M; Carradori T; Togliatto GM; Vaisitti T; Deaglio S
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology.
    Ponti G; Manfredini M; Tomasi A
    Crit Rev Oncol Hematol; 2019 Sep; 141():36-42. PubMed ID: 31212145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy.
    Zeng C; Stroup EK; Zhang Z; Chiu BC; Zhang W
    Cancer Commun (Lond); 2019 Mar; 39(1):12. PubMed ID: 30922396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Preanalytical and Analytical Methods on Cell-Free DNA Diagnostics.
    Krasic J; Abramovic I; Vrtaric A; Nikolac Gabaj N; Kralik-Oguic S; Katusic Bojanac A; Jezek D; Sincic N
    Front Cell Dev Biol; 2021; 9():686149. PubMed ID: 34552921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell free circulating tumor nucleic acids, a revolution in personalized cancer medicine.
    Kerachian MA; Poudineh A; Thiery JP
    Crit Rev Oncol Hematol; 2019 Dec; 144():102827. PubMed ID: 31715326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole exome sequencing of cell-free DNA - A systematic review and Bayesian individual patient data meta-analysis.
    Bos MK; Angus L; Nasserinejad K; Jager A; Jansen MPHM; Martens JWM; Sleijfer S
    Cancer Treat Rev; 2020 Feb; 83():101951. PubMed ID: 31874446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review.
    Cervena K; Vodicka P; Vymetalkova V
    Mutat Res Rev Mutat Res; 2019; 781():100-129. PubMed ID: 31416571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preanalytical variables that affect the outcome of cell-free DNA measurements.
    Ungerer V; Bronkhorst AJ; Holdenrieder S
    Crit Rev Clin Lab Sci; 2020 Nov; 57(7):484-507. PubMed ID: 32393081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell free DNA: revolution in molecular diagnostics - the journey so far.
    Nandi K; Verma R; Dawar R; Goswami B
    Horm Mol Biol Clin Investig; 2020 Feb; 41(1):. PubMed ID: 32083442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.